Skip to main content
. 2020 Dec 13;60(7):3307–3316. doi: 10.1093/rheumatology/keaa782

Fig. 4.

Fig. 4

HGF/CCL5 levels and obstetric complications

(A) Considering all patients, levels of hepatocyte growth factor (HGF) inversely correlated with the gestational week at delivery (r = 0.47, P < 0.05). (B, C) The inverse correlation is maintained in the rheumatic diseases group [other rheumatic diseases (ORD)+SSc; r = 0.5, P < 0.05] (B), but not in the healthy controls (HC) group (P > 0.05) (C). (D) Differences in HGF levels in patients with and without preterm delivery. (E) Chemokine (C-C motif) ligand 5 (CCL5) levels in patients with and without histological villitis. *P < 0.05, **P < 0.01.